Bowel Preparation as Residual Gastric Content Protection: Perioperative Management of GLP-1 Receptor Agonists in Adults Undergoing Combined Gastroscopy and Colonoscopy—Systematic Review and Meta-Analysis
Background/Objectives: GLP-1 and dual GLP-1/GIP receptor agonists (GLP-1 RAs) delay gastric emptying, increasing residual gastric content (RGC) during upper endoscopy (EGS) under standard fasting. Concurrent colonoscopy requires 24–48 h of a clear-liquid diet and osmotic bowel preparation, which may mitigate this risk without drug interruption. We conducted a systematic review and meta-analysis to quantify RGC rates in GLP-1 RA users undergoing combined same-session EGS and colonoscopy compared with EGS alone. Methods: MEDLINE and Cochrane CENTRAL were searched without date restriction. We included studies enrolling adults on GLP-1 RAs undergoing elective EGS with or without concurrent colonoscopy. The primary outcome was clinically significant RGC at the time of endoscopy. Random-effects inverse-variance meta-analysis was performed. Risk of bias was assessed with ROBINS-I and RoB 2. Certainty of evidence was assessed using the GRADE framework. Results: Of 1683 records identified, eight studies met eligibility criteria and were included. RGC rates in combined-procedure groups ranged from 0% to 4.9%. Pooled analysis demonstrated significantly higher odds of RGC among EGS-alone patients (OR 3.76, 95% CI 2.81–5.03; I2 = 0%). The effect was consistent across observational studies (OR 3.71, 95% CI 2.77–4.96; I2 = 0%) and directionally equal in the single RCT. No procedure was aborted due to RGC in the combined-procedure groups. Conclusions: In adults on GLP-1 RAs, concurrent colonoscopy with standard bowel preparation appears to effectively mitigate RGC risk during same-session EGS across eight studies with consistent, large-magnitude effect estimates. These findings support the hypothesis that bowel preparation achieves adequate gastric emptying, potentially obviating routine GLP-1 RA interruption in this procedural context.
Authors
- Y. Alshammari (ORCID: https://orcid.org/0000-0002-8025-6588)
- Saud M. Almutairi (ORCID: https://orcid.org/0009-0006-7105-8324)
- Yousif Murad (ORCID: https://orcid.org/0000-0003-1614-4597)
- Mukhammad David Naimzada (ORCID: https://orcid.org/0000-0002-7894-6029)
- Haytham H. Alabbas (ORCID: https://orcid.org/0000-0002-3018-6913)
- Bandar Alhaidari
- Mohammad Alenezi (ORCID: https://orcid.org/0000-0002-1769-1413)
- Ali A. Sabti (ORCID: https://orcid.org/0009-0009-5487-8621)
- Shahd Alhabib (ORCID: https://orcid.org/0009-0005-0693-9961)
- Sulaiman D. AlDuwaisan (ORCID: https://orcid.org/0009-0001-0059-1133)
- Ahmad Alhelila (ORCID: https://orcid.org/0009-0005-1764-267X)
- Raed Alotaibi
- Mohammad Alhajraf
- Haya Alquwaiz
- Ahmad Hameed Mohammad (ORCID: https://orcid.org/0009-0007-1672-0466)
Institutions
- University College Dublin (IE)
- Royal College of Surgeons in Ireland (IE)
- University of Ottawa (CA)
- King Faisal Specialist Hospital & Research Centre (SA)
- Kuwait Institute for Medical Specialization (KW)
- Centre of Advanced Studies (RU)
- Kursk State Medical University (RU)
Publication Details
- Journal
- Gastrointestinal Disorders
- Published
- 2026-11-12
- DOI
- https://doi.org/10.3390/gidisord8040077
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00